Frank Zhang (AP Images)
CAR-T filing in sight, Frank Zhang grabs full control of J&J-partnered Legend Biotech, steps down from GenScript
Two months after Yuan Xu steered Legend Biotech to a $424 million public debut on the Nasdaq, founder and chairman Frank Zhang is grabbing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
